Design and in vitro evaluation of novel sustained-release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers

References

• Grundy JS, Foster RT. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin Pharmacokinet 1996;30(1):28–51.
   Google Scholar
• Riis T, Bauer-Brand A, Wagner T, Kranz H. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. Eur J Pharm Biopharm 2007;65(1):78–84.
   PubMed Web of Science ®Google Scholar
• Varma MV, Kaushal AM, Garg S. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. J Control Release 2005;103(2):499–510.
   PubMed Web of Science ®Google Scholar
• Timmins P, Delargy AM, Howard JR. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet. Pharm Dev Technol 1997;2(1):25–31.
   PubMedGoogle Scholar
• Siepe S, Lueckel B, Kramer A, Ries A, Gurny R. Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int J Pharm 2006;316(1–2):14–20.
   PubMedGoogle Scholar
• Narisawa S, Nagata M, Hirakawa Y, Kobayashi M, Yoshino H. An organic acid-induced sigmoidal release system for oral controlled release preparations. III. Elucidation of the anomalous drug release behavior through osmotic pumping mechanism. Int J Pharm 1997;148(1):85–91.
   Google Scholar
• Espinoza R, Hong E, Villafuerte L. Influence of admixed citric acid in the release profile of pelanserin hydrochloride from HPMC matrix tablets. Int J Pharm 2000;201(2):165–173.
   PubMedGoogle Scholar
• Streubel A, Siepmann J, Dashevsky A, Bodmeier R. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J Control Release 2000;67(1):101–110.
   PubMed Web of Science ®Google Scholar
• Rao VM, Engh K, Qiu Y. Design of pH-independent controlled release matrix tablets for acidic drugs. Int J Pharm 2003;252(1–2):81–86.
   PubMedGoogle Scholar
• Maggi L, Machiste EO, Torre ML, Conte U. Formulation of biphasic release tablet containing slightly soluble drugs. Eur J Pharm Biopharm 1999;48(1):37–42.
   PubMed Web of Science ®Google Scholar
• The Merck Index. 13th. ed. Whitehouse Station, NJ: Merck & Co. Inc.; 2001.
   Google Scholar
• Homdrum EM, Likar R, Nell G. Xefo® Rapid: A novel effective tool for pain treatment. Eur Surg 2006;38(5):342–352.
   Google Scholar
• Kidd B, Frenzel W. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis. J Rheumatol 1996;23(9):1605–1611.
   PubMed Web of Science ®Google Scholar
• Balfour JA, Fitton A, Barradel LB. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996;51(4):639–657.
   Google Scholar
• Skjodt NM, Davies NM. Clinical pharmacokinetics of Lornoxicam. A short half-life oxicam. Clin Pharmacokinet 1998;34(6):421–428.
   PubMed Web of Science ®Google Scholar
• Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr 1984;5(3):1–9.
   Google Scholar
• Salsa T, Veiga G, Pina ME. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm 1997;23(9):292–938.
   Web of Science ®Google Scholar
• Pharmaceutical excipients from Dow water soluble polymers. 2002. Accessed from the website: http://www.dow.com.
   Google Scholar
• Lopes CM, Sousa Lobo JM, Pinto JF, Costa P. Compressed mini-tablets as a biphasic delivery system. Int J Pharm 2006;323(1–2):93–100.
   PubMed Web of Science ®Google Scholar
• Armstrong NA. Tablet manufacture. In: Encyclopedia of pharmaceutical technology. 3rd ed. USA: Informa Healthcare; 2007. p 3660.
   Google Scholar
• Al-Taani BM, Tashtoush BM. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium. AAPS Pharm Sci Tech 2003;4(3): article 43.
   PubMedGoogle Scholar
• Liew CV, Chan LW, Ching AL, Heng PW. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm 2006;309(1–2):25–37.
   PubMed Web of Science ®Google Scholar
• Pignatello R, Ferro M, Puglisi G. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions. AAPS Pharm Sci Tech 2002;3(2): article 10.
   Google Scholar
• The British Pharmacopoeia. British Pharmacopoeia Commission. London: HMSO; 2007 (electronic version).
   Google Scholar
• Varma MV, Kaushal AM, Garg S. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. J Control Release 2005;103(2):499–510.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, Paeratakul O. Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions. Pharm Res 1991;8(3):355–359.
   PubMed Web of Science ®Google Scholar
• Kumar SM, Chandrasekar MJ, Gopinath R, Srinivasan R, Nanjan MJ, Suresh B. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium. Drug Deliv 2007;14(3):163–169.
   PubMed Web of Science ®Google Scholar
• Rey H, Wagner KG, Wehrle P, Schmidt PC. Development of matrix-based theophylline sustained-release microtablets. Drug Dev Ind Pharm 2000;26(1):21–26.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20(6):64–74.
   Google Scholar
• Kerc J, Srcic S, Urleb U, Kanalec A, Kopler B, Smid-Korbar J. Compatibility study between acetylcysteine and some commonly used tablet excipients. J Pharm Pharmacol 1992;44(6):515–518.
   PubMed Web of Science ®Google Scholar
• Joshi BV, Patil VB, Pokharkar VB. Compatibility studies between carbamazepine and tablet excipients using thermal and non-thermal methods. Drug Dev Ind Pharm 2002;28(6):687–694.
   PubMed Web of Science ®Google Scholar
• Mora PC, Cirri M, Mura P. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations. J Pharm Biomed Anal 2006;42(1):3–8.
   PubMed Web of Science ®Google Scholar
• Tomassetti M, Catalnabi A, Rossi V, Vecchio S. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures. J Pharm Biomed Anal 2005;37(5):949–955.
   PubMed Web of Science ®Google Scholar
• Corti G, Cirri M, Maestrelli F, Mennini N, Mura P. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin. Eur J Pharm Biopharm 2008;68(2):303–309.
   PubMed Web of Science ®Google Scholar
• Vueba ML, Batista de Carvalho LA, Veiga F, Souza JJ, Pina ME. Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev Ind Pharm 2005;31(7):653–665.
   PubMed Web of Science ®Google Scholar
• Vueba ML, Batista de Carvalho LA, Veiga F, Souza JJ, Pina ME. Influence of cellulose ether mixtures on ibuprofen release: MC25, HPC and HPMC K100M. Pharm Dev Technol 2006;11(2):213–228.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48(2–3):139–157.
   PubMed Web of Science ®Google Scholar
• Botha SA, Lötter AP. Compatibility study between naproxen and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm 1990;16(4):673–683.
   Web of Science ®Google Scholar
• Ribeiro L, Ferreira DC, Veiga FJ. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. J Control Release 2005;103(2):325–339.
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG. A comparative study of the gastrointestinal transit of a pellet and tablet formulation. Int J Pharm 1984;21(2):167–177.
   Web of Science ®Google Scholar
• Nellore RV, Rekhi GS, Hussain AS, Tillman LG, Augsburger LL. Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration. J Control Release 1998;50(1–3):247–256.
   PubMed Web of Science ®Google Scholar
• Reynolds TD, Gehrke SH, Hussain AS, Shenouda LS. Polymer erosion and drug release characterization of hydroxypropylmethylcellulose matrices. J Pharm Sci 1998;87(9):1115–1123.
   PubMed Web of Science ®Google Scholar
• Kuksal A, Tiwary AK, Jain NK. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm Sci Tech 2006;7(1): article 1.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Ganga S, Saha RN. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Chem Pharm Bull 2008;56(4):518–524.
   PubMed Web of Science ®Google Scholar
• Ochoa L, Igartua M, Hernandez RM, Gascon AR, Pedraz JL. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J Pharm Pharmceut Sci 2005;8(2):132–140.
   PubMed Web of Science ®Google Scholar
• Ju RT, Nixon PR, Patel MV. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J Pharm Sci 1995;84(12):1455–1463.
   Google Scholar
• Siepmann J, Streubel A, Peppas NA. Understanding and predicting drug delivery from hydrophilic matrix tablets using the “sequential layer” model. Pharma Res 2002;19(3):306–314.
   Google Scholar
• Campos-Aldrete ME, Villafuerte-Robles L. Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur J Pharm Biopharm 1997;43(2):173–178.
   Web of Science ®Google Scholar
• Cohen JL, Hubert BB, Rhodes CT. The development of USP dissolution and drug release standards. Pharm Res 1990;7(10):983–987.
   PubMed Web of Science ®Google Scholar
• Amaral HM, Lobo JM, Ferreira DC. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained release tablets. AAPS Pharm Sci Tech 2001;2(2): article 6.
   PubMedGoogle Scholar
• Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm 2008;69(3):1019–1028.
   PubMed Web of Science ®Google Scholar
• Conti S, Maggi L, Segale L, Ochoa Machiste E, Conte U, Grenier P, Vergnault G. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study. Int J Pharm 2007;333(1–2):143–151.
   Google Scholar
• Papadimitriou E, Buckton G, Efentakis M. Probing the mechanisms of swelling of hydroxypropylmethylcellulose matrices. Int J Pharm 1993;98(1–3):57–62.
   Google Scholar
• Nalluri BN, Chowdary KP, Murthy KV, Becket G, Crooks PA. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems. AAPS Pharm Sci Tech 2007;8(2): article 36.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Ganga S, Saha RN. Design and study of lamivudine oral controlled release tablets. AAPS Pharm Sci Tech 2007;8(4): article 101.
   Web of Science ®Google Scholar
• Chopra S, Patil GV, Motwani SK. Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design. Eur J Pharm Biopharm 2007;66(1):73–82.
   PubMed Web of Science ®Google Scholar